Facultad de Ciencias de la Salud
Facultad
Hospital Universitari Germans Trias i Pujol
Barcelona, EspañaHospital Universitari Germans Trias i Pujol -ko ikertzaileekin lankidetzan egindako argitalpenak (100)
2024
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
2022
2021
-
Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
Infectious Diseases and Therapy, Vol. 10, Núm. 1, pp. 347-362
-
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
Blood Cancer Journal, Vol. 11, Núm. 5
-
Management of postanalytical processes in the clinical laboratory according to ISO 15189:2012 Standard requirements: Considerations on the review, reporting and release of results
Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 51-59
-
The importance of understanding the stages of covid-19 in treatment and trials
AIDS Reviews, Vol. 23, Núm. 1, pp. 40-47
-
The time to offer treatments for COVID-19
Expert Opinion on Investigational Drugs, Vol. 30, Núm. 5, pp. 505-518
2020
2019
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
2018
-
HIV in Spain 2017: Policies for a new management of chronicity beyond virological control
Revista Espanola de Salud Publica, Vol. 92
2017
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
2016
-
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 1056-1062
-
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy
HIV Medicine, Vol. 17, Núm. 6, pp. 471-478
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
-
Infection-related and -unrelated malignancies, HIV and the aging population
HIV Medicine, Vol. 17, Núm. 8, pp. 590-600
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
2015
-
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study
HIV Medicine, Vol. 16, Núm. 9, pp. 533-543
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3